TriSalus Life Sciences (NASDAQ:TLSIW) Shares Climb 31.4% – What’s Next?

TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) traded up 31.4% on Wednesday. The stock traded as high as $0.9399 and last traded at $0.7360. 1,810 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 4,865 shares. The stock had previously closed at $0.56.

TriSalus Life Sciences Stock Up 31.4%

The business has a 50 day moving average price of $0.86 and a 200-day moving average price of $0.97.

Hedge Funds Weigh In On TriSalus Life Sciences

An institutional investor recently bought a new position in TriSalus Life Sciences stock. State Street Corp acquired a new stake in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 610,963 shares of the company’s stock, valued at approximately $2,780,000.

TriSalus Life Sciences Company Profile

TriSalus Life Sciences is an oncology-focused medical technology and therapeutics company developing products intended to improve the treatment of solid tumors, particularly cancers of the liver and pancreas. The company’s approach is designed to address the biological and physical barriers that can limit the delivery of therapies into tumors.

Its primary technology is Pressure-Enabled Drug Delivery (PEDD), which uses specialized infusion systems to administer treatments directly to tumors or tumor-feeding blood vessels.